Compare ABT & APP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ABT | APP |
|---|---|---|
| Founded | 1888 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 222.8B | 228.2B |
| IPO Year | N/A | 2021 |
| Metric | ABT | APP |
|---|---|---|
| Price | $124.69 | $697.40 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 18 | 17 |
| Target Price | $146.61 | ★ $761.94 |
| AVG Volume (30 Days) | ★ 5.5M | 3.5M |
| Earning Date | 01-21-2026 | 02-11-2026 |
| Dividend Yield | ★ 2.02% | N/A |
| EPS Growth | 141.97 | ★ 144.05 |
| EPS | 7.96 | ★ 7.98 |
| Revenue | ★ $43,843,000,000.00 | $6,307,450,000.00 |
| Revenue This Year | $7.57 | $22.21 |
| Revenue Next Year | $7.96 | $37.22 |
| P/E Ratio | ★ $15.68 | $89.46 |
| Revenue Growth | 6.37 | ★ 98.48 |
| 52 Week Low | $110.86 | $200.50 |
| 52 Week High | $141.23 | $745.61 |
| Indicator | ABT | APP |
|---|---|---|
| Relative Strength Index (RSI) | 46.16 | 56.11 |
| Support Level | $123.85 | $710.25 |
| Resistance Level | $125.33 | $738.01 |
| Average True Range (ATR) | 2.09 | 28.39 |
| MACD | 0.04 | -0.53 |
| Stochastic Oscillator | 44.97 | 52.84 |
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.
AppLovin is a vertically integrated advertising technology company that acts as a demand-side platform for advertisers, a supply-side platform for publishers, and an exchange facilitating transactions between the two. About 80% of AppLovin's revenue comes from the DSP, AppDiscovery, while the remainder comes from the SSP, Max. AppLovin's primary tool for future growth is AXON 2, which is an ad optimizer operating within the DSP that allows advertisers to place ads according to specified return thresholds.